Author:
Cohen Danielle,Hondelink Liesbeth M.,Solleveld-Westerink Nienke,Uljee Sandra M.,Ruano Dina,Cleton-Jansen Anne-Marie,von der Thüsen Jan H.,Ramai S. Rajen S.,Postmus Pieter E.,Graadt van Roggen Jacob F.,Hoppe Bart P.C.,Clahsen Pieter C.,Maas Klaartje W.,Ahsmann Els J.M.,ten Heuvel Alexandra,Smedts Frank,van Rossem Ronald N.,van Wezel Tom
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference52 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Howlader N, Noone AM, Krapcho M, et al. Contents of the SEER Cancer Statistics Review (CSR), 1975-2016. Bethesda, MD, National Cancer Institute; 2019. Bethesda, MD, US Department of Health and Human Services.
3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004
4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004
5. Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer;Cardarella;Clin Cancer Res,2013
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献